Overview

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

Status:
Withdrawn
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of itraconazole after multiple dose administration on the single dose PK of PF-06372865.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Hydroxyitraconazole
Itraconazole
PF-06372865